Holen Sie sich die Stockscreener-App
2.26
5.83%
-0.14
Handel nachbörslich:
2.27
0.01
+0.44%
Schlusskurs vom Vortag:
$2.40
Offen:
$2.4
24-Stunden-Volumen:
8.99M
Relative Volume:
0.94
Marktkapitalisierung:
$2.14B
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-597.65M
KGV:
-2.3299
EPS:
-0.97
Netto-Cashflow:
$-425.62M
1W Leistung:
-15.04%
1M Leistung:
-11.02%
6M Leistung:
-11.02%
1J Leistung:
-57.20%
1-Tages-Spanne:
$2.25
$2.40
1-Wochen-Bereich:
$2.25
$2.66
52-Wochen-Spanne:
$1.83
$5.88
Immunitybio Inc Stock (IBRX) Company Profile
Firmenname
Immunitybio Inc
Sektor
Branche
Telefon
(844) 696-5235
Adresse
3530 JOHN HOPKINS COURT, SAN DIEGO
Vergleichen Sie IBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.26 | 2.36B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | BTIG Research | Buy |
| 2023-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | Eingeleitet | Jefferies | Buy |
Immunitybio Inc Aktie (IBRX) Neueste Nachrichten
What moving averages say about ImmunityBio Inc.Market Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Will ImmunityBio Inc. stock continue upward momentum2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Why ImmunityBio Inc. (26CA) stock stays undervaluedVolume Spike & Pattern Based Trade Signal System - newser.com
Will ImmunityBio Inc. (26CA) stock justify high valuationExit Point & Verified High Yield Trade Plans - newser.com
How ImmunityBio Inc. (26CA) stock responds to bond market2025 Market Outlook & Proven Capital Preservation Tips - newser.com
Is ImmunityBio Inc. stock a buy on dipsQuarterly Portfolio Report & Low Volatility Stock Recommendations - newser.com
ImmunityBio Inc. recovery potential after sell offMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Tick level data insight on ImmunityBio Inc. volatilityJuly 2025 Reactions & Growth Focused Stock Reports - newser.com
ImmunityBio Inc Stock Analysis and ForecastStock Watchlist Updates & Small Investment Growth Tips - earlytimes.in
Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionMarket Growth Report & Community Consensus Stock Picks - newser.com
How ImmunityBio Inc. (26CA) stock compares with tech leadersQuarterly Investment Review & Daily Growth Stock Tips - newser.com
ImmunityBio, Inc. (IBRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Applying big data sentiment scoring on ImmunityBio Inc.Bear Alert & Safe Capital Growth Tips - newser.com
ImmunityBio, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Why retail investors favor ImmunityBio Inc. stock2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Can machine learning forecast ImmunityBio Inc. recoveryWatch List & High Accuracy Swing Entry Alerts - newser.com
What drives ImmunityBio Inc 26CA stock priceIPO Market Watch & Low Risk Capital Appreciation - earlytimes.in
How hedge fund analytics apply to ImmunityBio Inc. stockPortfolio Update Summary & Reliable Entry Point Trade Alerts - newser.com
Why ImmunityBio Inc. (26CA) stock is a strong analyst pickPortfolio Value Summary & High Yield Stock Recommendations - newser.com
Finanzdaten der Immunitybio Inc-Aktie (IBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):